10YR企业会员
英文名称 | 中文名称 | CAS |
---|---|---|
Dynasore | DYNASORE | 304448-55-3 |
AK120765 | AK120765 | 955272-06-7 |
DMU2105 | CS-2868 | 1031063-36-1 |
JAK3-IN-6 | JAK3-IN-6 | 1443235-95-7 |
MAC-545496 | MAC-545496 | 838810-96-1 |
Datelliptium chloride | 2-[2-(二乙氨基)乙基]-9-羟基-5,11-二甲基-6H-吡啶并[4,3-B]咔唑 | 105118-14-7 |
Abexinostat (PCI-24781) | PCI-24781 | 783355-60-2 |
BMS-687453 | BMS 687453 | 1000998-59-3 |
SI-60 | (4-羟基苯基)(甲基)(萘-1-基甲基)锍六氟锑酸盐 | 133152-67-7 |
VLX600 | VLX600 | 1622945-04-3 |
AM-0902 | AM0902 | 1883711-97-4 |
MRT68921 HCI | MRT68921 HCl | 2070014-87-6 |
Tegobuvir | 5-[[6-[2,4-双(三氟甲基)苯基]-3-哒嗪基]甲基]-2-(2-氟苯基)-5H-咪唑并[4,5-C]吡啶 | 1000787-75-6 |
Aripiprazole Dimer Impurity | 阿立哌唑二聚物 | 1797986-18-5 |
CK869 | CK-869 | 388592-44-7 |
PEO-IAA | 2-(1H-吲哚-3-基)-4-氧基-4-苯基亮氨酸 | 6266-66-6 |
ACY-775 | CS-2821 | 1375466-18-4 |
E-7046 | E-7046 | 1369489-71-3 |
PF-4878691 | 532959-63-0 | 532959-63-0 |
SB366791 | 3-(4-氯苯基)-N-(3-甲氧基苯基)-2-丙烯酰胺 | 472981-92-3 |
AMG-510 | AMG-510(消旋体) | 2252403-56-6 |
TH 5487 | TH 5487 | 2304947-71-3 |
SU-5607 | IC261游离态 | 186611-52-9 |
KN-93 base or HCI | (E)-N-(2-(((3-(4-氯苯基)烯丙基)(甲基)氨基)甲基)苯基)-N-(2-羟乙基)-4-甲氧基苯磺酰胺 | 139298-40-1 |
metipranolol | 美替洛尔 | 22664-55-7 |
Fumagillol | 烟曲霉醇 | 108102-51-8 |
mTOR inhibitor-1 | 152-53-4 | 468747-17-3 |
AC5216 | AC-5216 | 226954-04-7 |
CHIR-98014 | CHIR98014(CT98014) | 252935-94-7 |
XMD 8-92 | 2-[[2-乙氧基-4-(4-羟基-1-哌啶基)苯基]氨基]-5,11-二氢-5,11-二甲基-6H-嘧啶并[4,5-B][1,4]苯并二氮杂卓-6-酮 | 1234480-50-2 |
PD0166285 | 6-(2,6-二氯苯基)-2-[[4-[2-(二乙基氨基)乙氧基]苯基]氨基]-8-甲基吡啶并[2,3-D]嘧啶-7(8H)-酮 | 185039-89-8 |
LEE011 (Ribociclib) | 瑞博西尼 | 1211441-98-3 |
G007-LK | G007-LK | 1380672-07-0 |
WH-4-023 | 2,6-DIMETHYLPHENYL 2,4-DIMETHOXYPHENYL(2-(4-(4-METHYLPIPERAZIN-1-YL)PHENYLAMINO)PYRIMIDIN-4-YL)CARBAMATE | 837422-57-8 |
BI671800 | 2 - [ 4- [ 4 -(三氟甲基)苯甲酰胺基] ] ]苯甲基4,6 -二(二甲氨基) -嘧啶-5-乙酸 | 1093108-50-9 |
JNJ26854165 2HCl | Quisinostat 二盐酸盐 | 875320-31-3 |
IDE196 | LXS-196 | 1874276-76-2 |
DMU2139 | CS-2867 | 104890-70-2 |
TRi-1 | TRi-1 | 246020-68-6 |
yGsy2p-IN-1 | 化合物YGSY2P-IN-1 | 2415003-97-1 |
Pixantrone maleate | 马来到匹杉琼 | 144675-97-8 |
Aurora kinase inhibitor III | AURORA KINASE INHIBITOR III | 879127-16-9 |
SGI 1027 | SGI-1027 | 1020149-73-8 |
CPI-444 | CPI-444 | 1202402-40-1 |
Ellipticine hydrochloride | 玫瑰树碱盐酸盐 | 5081-48-1 |
AF64394 | CS-2866 | 1637300-25-4 |
BO-264 | BO-264 | 2408648-20-2 |
KN92 phosphate | KN92 游离和盐酸盐 | 1135280-28-2 |
GSK2801 | 1-(1-(2-(甲磺酰)苯基)-7-丙氧基吲哚嗪-3-基)乙酮 | 1619994-68-1 |
Seclidemstat | SECLIDEMSTAT | 1423715-37-0 |
GLX351322 | CS-2871 | 835598-94-2 |
ZT-12-037-01 | ZT-12-037-01 | 2328073-61-4 |
NTP-42 | NTP-42 | 2055599-51-2 |
NS-3-008 | NS-3-008(HCl) | 1172854-54-4 |
4-(Chloromethyl)-2,6-dimethylpyridine | 2,6-二甲基-4-氯甲基吡啶 | 120739-87-9 |
GlyH-101 | GLYH 101 | 328541-79-3 |
Lersivirine(UK 453061) | 3-氰基-5-[[3,5-二乙基-1-(2-羟基乙基)-1H-吡唑-4-基]氧基]苯腈 | 473921-12-9 |
SD-06-1 | 3-[N-(2-羟基乙酰基)-4-哌啶基]-4-(4-嘧啶基)-5-(4-氯苯基)吡唑 | 271576-80-8 |
FG2216 | BIQ | 223387-75-5 |
GKT137831 | 2-(2-氯苯基)-4-[3-(二甲基氨基)苯基]-5-甲基-1H-吡唑并[4,3-C]吡啶-3,6(2H,5H)-二酮 | 1218942-37-0 |
Voxtalisib (XL765, SAR245409) | 2-氨基-8-乙基-4-甲基-6-(1H-吡唑-3-基)吡啶并[2,3-d]嘧啶-7(8H)-酮 | 934493-76-2 |
TD-4208 | 雷芬那辛 | 864750-70-9 |
XMU-MP-1 | XMU-MP-1 | 2061980-01-4 |
IDF-11774 | 无中文名称 | 1429054-28-3 |
SBI-115 | SBI-115 | 882366-16-7 |
SSE15206 | 1370046-40-4 | 1370046-40-4 |
ZM223 | ZM223;ZM-223;ZM 223 | 2031177-48-5 |
NDI-091143 | NDI-091143 | 2375840-87-0 |
FEN1 Inhibitor C2 | FEN1 Inhibitor C2 | 1995893-58-7 |
GW2580 | GW2580 | 870483-87-7 |
CWHM-12 | CWHM-12 | 1564286-55-0 |
Defactinib hydrochloride | 地法替尼盐酸盐 | 1073160-26-5 |
Voxelotor(GBT440, GTx011) | 沃塞洛托 | 1446321-46-5 |
ON123300 | 8-环戊基-7,8-二氢-2-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-7-氧代-吡啶并[2,3-D]嘧啶-6-甲腈 | 1357470-29-1 |
SGC2085 | SGC2085 | 1821908-48-8 |
AMG-3969 | AMG-3969 | 1361224-53-4 |
XMD-17-51 | XMD-17-51 | 1628614-50-5 |
TRPM8 antagonist 2 | TRPM8 拮抗剂 | 259674-19-6 |
ML-109 | ML-109 | 1186649-91-1 |
PD173955 | 6-(2,6-二氯苯基)-8-甲基-2-[[3-(甲硫基)苯基]氨基]吡啶并[2,3-D]嘧啶-7(8H)-酮 | 260415-63-2 |
ID 8 free base | 1-(4-甲氧基苯基)-2-甲基-3-硝基-1H-吲哚-6-醇 | 147591-46-6 |
LY2886721 HCl | N-[3-[(4AS,7AS)-2-氨基-5,7-二氢-4H-呋喃并[3,4-D][1,3]噻嗪-7A(4AH)-基]-4-氟苯基]-5-氟-2-吡啶甲酰胺盐酸盐 | 1262036-49-6 |
KD025 (SLx-2119) | 2-[3-[4-[(1H-吲唑-5-基)氨基]喹唑啉-2-基]苯氧基]-N-异丙基乙酰胺 | 911417-87-3 |
AS1517499 | AS1517499 | 919486-40-1 |
Glasdegib | 格拉斯吉布 | 1095173-27-5 |
FRAX486 | FRAX486 | 1232030-35-1 |
ON1231320 | CS-2589 | 1312471-39-8 |
ACH-4471 | Danicopan | 1903768-17-1 |
AZD 7648 | AZD-7648 | 2230820-11-6 |
C75 | 反-4-羧基-5-辛基-3-甲基-丁内酯 | 191282-48-1 |
Fatostatin A | FATOSTATIN A | 125256-00-0 |
Hydroxy-Dynasore | DYNGO-4A | 1256493-34-1 |
MHY1485 | MHY1485 | 326914-06-1 |
MD2-IN-1 | MD2-IN-1 | 111797-22-9 |
(+/-)-BAY K 8644 | 1,4-二氢-2,6-二甲基-5-硝基-4-(2-三氟甲基苯基)吡啶-3-羧酸甲酯 | 71145-03-4 |
SJA710-6 | SJA710 6; SJA710-6; SJA-710-6; SJA 710-6 | 1397255-09-2 |
ERK5-IN-2 | ERK5-IN-2 | 1888305-96-1 |
LY-3381916 | LY-3381916 | 2166616-75-5 |
FEN1 Inhibitor C3 | 3-羟基-1-(4-甲氧基苯基)喹唑啉-2,4(1H,3H)-二酮 | 2109805-87-8 |
TYRPHOSTIN AG 528 | 酪氨酸磷酸化抑制剂AG528 | 133550-49-9 |
联系方式